Aurora Cannabis Expands Medical Portfolio in Australia & New Zealand
NASDAQ | TSX: ACB
Launch reinforces Aurora's leadership position across key international markets
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), a prominent Canadian leader in the medical cannabis sector, is making significant strides in expanding its product line within Australia and New Zealand. This strategic move not only enhances patient and prescriber choices but also reinforces the commitment to delivering science-backed cannabis solutions. This initiative reflects Aurora’s aim to adapt to the evolving needs of patients and healthcare professionals in the region.
This month marks an exciting expansion in New Zealand with the introduction of two new THC flower products: Big Wave™ and Night Ride™, alongside the upcoming release of the balanced strain, Half Moon™ expected in the first quarter of the fiscal year. In Australia, Aurora will unveil four innovative resin cartridges this month, namely Chemango™ Kush, Cosmic Cream™, Lunar Express™, and Soul Train Haze™.
"Australia is one of our largest markets for medical cannabis, and both Australia and New Zealand are high on our priority list for ongoing investments," says Stanley Sack, Interim Managing Director of MedReleaf Australia. He further adds, "As patient requirements evolve, it's our duty to provide high-quality, diverse product formats, which in turn enable prescribers to deliver superior care to their patients. Our unwavering focus on quality ensures that patients have reliable access to the products they trust."
All new offerings utilize Aurora’s proprietary genetics and are produced at the company’s state-of-the-art manufacturing facilities, certified under EU-GMP and TGA-GMP standards, ensuring the highest levels of quality and safety.
New Zealand Launches
The following products are now available in New Zealand:
- Big Wave™ – Flower, Hybrid, THC 26%, CBD <1%
- Night Ride™ – Flower, Indica, THC 29%, CBD <1%
- Half Moon™ – Flower, Hybrid, THC 9%, CBD 13%
Australia Launches
Aurora's product roll-out in Australia includes:
- Chemango™ Kush – Resin Cartridge, Indica, THC 780mg/g, CBD <10mg/g
- Cosmic Cream™ – Resin Cartridge, Indica, THC 780 mg/g, CBD <10mg/g
- Lunar Express™ - Resin Cartridge, Indica, THC 780mg/g, CBD <10mg/g
- Soul Train Haze™ – Resin Cartridge, Sativa, THC 780mg/g, CBD <10mg/g
Renowned for its consistent quality, Aurora Cannabis remains a preferred choice for both prescribers and patients worldwide. With a comprehensive range of high-quality medical cannabis products and proven regulatory know-how, Aurora stands at the forefront of patient care initiatives.
About Aurora Cannabis
Aurora Cannabis is a pioneer in the medical cannabis industry, committed to enhancing lives through scientific expertise and dedicated patient care. The company serves both medical and recreational markets across Canada, Europe, Australia, and New Zealand. Focusing on high-margin opportunities along with a medical-first approach has been key to its success. Aurora is recognized for its trusted brands including Aurora®, MedReleaf®, and others. Moreover, the company maintains a significant stake in Bevo Farms Ltd., a leading supplier of propagated agricultural products. Aurora’s state-of-the-art GMP-certified manufacturing facilities located in Canada and Germany are integral to its mission of delivering superior cannabis products globally.
For more information, visit www.auroramj.com and follow us on X and LinkedIn.
Aurora's common shares are traded on both the NASDAQ and TSX under the ticker symbol ACB.
Frequently Asked Questions
What products has Aurora launched in Australia and New Zealand?
Aurora has introduced new THC flower products in New Zealand and launched resin cartridges in Australia, expanding patient options.
What is the focus of Aurora's portfolio expansion?
The expansion focuses on meeting patient needs, providing high-quality products, and supporting prescribers with reliable access to cannabis solutions.
How does Aurora ensure product quality?
All products are manufactured at EU-GMP and TGA-GMP certified facilities, ensuring strict adherence to quality and safety standards.
What is Aurora's approach to patient care?
Aurora emphasizes a medical-first approach, focusing on developing high-margin products while ensuring patient care and satisfaction.
Where can I find more about Aurora's offerings?
Visit Aurora's official website at www.auroramj.com for comprehensive information on their medical cannabis products and company updates.
